NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
TerminatedPhase 1
Sponsor: University Hospital, Lille
Conditions: Alzheimer Disease, Battery
Interventions: Memantine, Placebo
Countries: France
The early assessment of new drugs for Alzheimer's disease remains difficult because of the lack of predictive end-point. The use of a battery including different parameters could improve this early development of new drugs. Nevertheless, the interest of such a battery should previously be validated with the yet marketed AD drugs.
Eligibility overview
Sex: MALE
Age: 18 Years to 30 Years
Healthy volunteers: Yes
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: * 18-30 year old male non-smoker subjects * Subject without cognitive impairment or cognitive complaint (Moca\>26, Mac Nair scale\<15) * Subject without history of brain disease (severe brain trauma, stroke, cerebral tumor,…) * Subject without major medical or surgical history * Subject without current chronic disease * Subject without current cerebral disease * Subject without vascular or metabolic risk factor * Subject without history or current mental disease or addiction (MINI) * Subject without lesion on MRI * Subject without abnormal electrical activities on EEG * Subject without use of chronic treatment or psychotropic drugs or substances * French speaker subject and able to understand the test instructions Exclusion Criteria: * Subject with dementia or cognitive decline identified by Moca \< 26 * Subject with vascular or metabolic risk factor * Subject with history or current mental disease or addiction * Subject with family history of young-onset dementia * Subject with family history of chronic or severe neurological or mental disease (first degree relatives) * Subject receiving a chronic treatment * Subject with claustrophobia or contra-indication to MRI * Subject unable to understand the test instructions
Locations (3)
- Lille, France
- Marseille, France
- Toulouse, France